2021 USCAP 110th ANNUAL MEETING Long Course Pulmonary Pathology : Practical Problems And Solutions

Course Description

Clinical management of neoplastic and non-neoplastic lung diseases has changed significantly in the past decade. Therefore, there is much greater pressure on the practicing pathologist not only to make the correct diagnosis, but also to guide therapeutic decisions and management of patients with lung diseases. This course will provide a detailed discussion on potentially difficult aspects of recent recommendations for the classification of chronic interstitial pneumonias, challenging areas of the upcoming WHO classification of lung and mesothelial tumors, and recently recognized biomarkers of response to immune check point inhibitors. An update on acute lung injury in the context of the recent E-cigarette/vaping outbreak and COVID pandemic will be provided. Upon completion of the course participants should be able to integrate histology, radiology, emerging molecular techniques and clinical information in the diagnosis of thoracic entities.

Learning Objectives

  • Update current knowledge on recent advances and practice guidelines in neoplastic and non-neoplastic diagnostic thoracic pathology
  • Recognize key morphological features, mimickers, and ancillary studies that can help in making a specific and accurate diagnosis in thoracic pathology
  • Integrate histology, ancillary techniques and clinical information in the diagnosis and management of difficult diagnostic areas of thoracic neoplastic and non-neoplastic pathology

Target Audience

  • Practicing academic pathologists
  • Practicing community pathologists
  • Pathologists-in-Training
FACULTY TITLE
Sanja Dacic, MD, PhD
University of Pittsburgh
Introduction
Mary Beth Beasley, MD
Mount Sinai Medical Center, New York
Acute lung injury: From Cannabis to COVID
In order of preferred presentation for on-demand viewing
FACULTY TITLE
Maxwell L. Smith, MD
Mayo Clinic Arizona
Diagnosis of IPF/UIP- where we are and where we need to go
Andrew Churg, MD, PhD
The University of British Columbia
Chronic hypersensitivity pneumonitis practice recommendations and challenges
Alain Borczuk, MD
Weill Cornell Medicine
Different faces of invasion in lung carcinoma
Natasha Rekhtman, MD, PhD
Memorial Sloan Kettering Cancer Center
Department of Pathology
Neuroendocrine tumors of the lung- a decade of change
Sanja Dacic, MD, PhD
University of Pittsburgh
Pleural mesothelioma classification –update and challenges
Jennifer M. Boland Froemming, MD
Mayo Clinic
Unusual lung tumors –from morphology to genetics
Lynette M. Sholl, MD
Brigham and Women’s Hospital, Harvard Medical School
Biomarkers of response to check point inhibitors– beyond PD-L1

Release Date : Saturday, March 13, 2021

 


Details : 9 Videos , 1 PDF

Price : $ 60

BUY

Leave a Reply

Your email address will not be published. Required fields are marked *